Single Pass has announced that its Kronos biopsy closure device, a Class II medical device, has received clearance from the US Food and Drug Administration (FDA). The FDA has confirmed that the ...
NEWARK, Del, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The global biopsy device market is on track for steady growth over the next decade, with a projected valuation of USD 2,274.1 million in 2024 ...
The global cold disposable biopsy forceps market is expected to achieve a valuation of USD 634.6 million in 2023, with ...
The biopsy devices market, valued at USD 2.3 billion in 2022, is poised for significant expansion, projected to reach USD 4.2 billion by 2032 at a robust CAGR of 6.1% from 2023 to 2032. This market ...
Dublin, Nov. 13, 2024 (GLOBE NEWSWIRE) -- The "Innovations and Growth Opportunities in the Biopsy Industry, 2024-2028" report has been added to ResearchAndMarkets.com's offering. This analysis ...